Tumor Response Predicts Survival Time of Ramucirumab Plus Irinotecan in Advanced Gastric Cancer: An Exploratory Analysis of the Phase III RINDBeRG Trial

Toshifumi Yamaguchi, Hiroki Yukami, Hiroyuki Kodama, Yoshihiro Okita, Takeshi Shiraishi,

Daisuke Kobayashi, Kiyoshi Ishigure, Ko Takachi, Shunji Endo, Toshio Shimokawa, Daisuke Sakai,

Taroh Satoh

第98回日本胃癌学会総会（JGCA2026）2026.3.4-6　沖縄